FCM
ENFN

FJ Capital Management’s Enfusion, Inc. ENFN Stock Holding History

FJ Capital Management’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-21,990
Closed -$280K – 111
2022
Q1 		$280K Buy
+21,990
New +$336K 0.02% 98

Other funds holding ENFN

FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
ACM
Ararat Capital Management Westport, Connecticut $178M AUM 26.61% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FJ Capital Management's ENFN Position: Q2 2022 in Review

FJ Capital Management sold out of Enfusion, Inc. (ENFN) in Q2 2022, closing a stake of 21,990 shares — an estimated $280K sold.

FJ Capital Management first reported a position in ENFN in Q1 2022 and held it in 1 quarter. The position peaked at $280K in Q1 2022. 62 funds tracked by Wall St. Rank hold ENFN as of Q2 2022.

  • FJ Capital Management reported no remaining Enfusion, Inc. position as of Q2 2022 after selling out during the quarter.
  • FJ Capital Management sold 21,990 Enfusion, Inc. shares in Q2 2022, an estimated $280K.
  • FJ Capital Management first reported a position in Enfusion, Inc. in Q1 2022 and held it in 1 quarter.
  • FJ Capital Management's Enfusion, Inc. position peaked at $280K in Q1 2022.
  • 62 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2022.

Based on FJ Capital Management's 13F filing for Q2 2022, filed 11 Aug 2022.